Cm. Salafia et Al. Parke, PLACENTAL PATHOLOGY IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND PHOSPHOLIPID ANTIBODY SYNDROME, Rheumatic diseases clinics of North America, 23(1), 1997, pp. 85
Fetal loss is increased in women who meet the Arthritis and Rheumatism
Association criteria for systemic lupus erythematosus (SLE) and in wo
men who have phospholipid antibody syndrome (APS). There are multiple
causes for this fetal loss, and in patients with SLE, disease activity
appears to be an important contributing factor. Ln APS patients, it a
ppears that some individuals will experience recurrent fetal loss and
will continuously fail to complete pregnancy naturally. Placental exam
ination has helped to elucidate some of the pathology that may contrib
ute to this fetal loss and our studies have shown that the same pathol
ogy is repeated in subsequent pregnancies. Placental examination in SL
E or APS patients with recurrent fetal loss is vital if we are going t
o be able to determine appropriate therapy to prevent fetal loss.